Expert Interview
A Look at Pfizer's oral COVID-19 antiviral Paxlovid
Ticker(s): PFEInstitution: California Pacific Medical Center
- Infectious Disease Specialist in San Francisco, CA and has over 43 years of experience in the medical field.
- Currently has 1 patient on the course, but has prescribed 20 altogether.
- Is very familiar with the oral antiviral and its rebound effects/potential dangers with contraindication
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
